The role of inflammation in cancer of the esophagus
-
K. E. O'Sullivan; J. J. Phelan; C. O'Hanlon; J. Lysaght; J. N. O'Sullivan; J. V. Reynolds
The role of inflammation in cancer of the esophagus Expert Rev Gastroenterol Hepatol
Publication Category: Cancer
Obesity and anastomotic leak rates in colorectal cancer: a meta-analysis
-
T. S. Nugent; M. E. Kelly; N. E. Donlon; M. R. Fahy; J. O. Larkin; P. H. McCormick; B. J. Mehigan
Obesity and anastomotic leak rates in colorectal cancer: a meta-analysis Int J Colorectal Dis
Help or hindrance: The obesity paradox in cancer treatment response
-
F. O'Connell; J. O'Sullivan
Help or hindrance: The obesity paradox in cancer treatment response Cancer Lett
Obesity and cardiovascular risk in an oncology day ward population
- D. O'Reilly; L. Prior; L. Dooley; P. Calvert; M. O'Connor; A. Horgan; E. Jordan Obesity and cardiovascular risk in an oncology day ward population Ir J Med Sci
Obesity, Aspirin, and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study
-
M. Movahedi; D. T. Bishop; F. Macrae; J. P. Mecklin; G. Moeslein; S. Olschwang; D. Eccles; D. G. Evans; E. R. Maher; L. Bertario; M. L. Bisgaard; M. G. Dunlop; J. W. Ho; S. V. Hodgson; A. Lindblom; J. Lubinski; P. J. Morrison; V. Murday; R. S. Ramesar; L.
Obesity, Aspirin, and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study J Clin Oncol
Natural killer cell therapy: A new frontier for obesity-associated cancer
-
E. Mylod; J. Lysaght; M. J. Conroy
Natural killer cell therapy: A new frontier for obesity-associated cancer Cancer Lett
Fractalkine Elicits Chemotactic, Phenotypic, and Functional Effects on CX3CR1(+)CD27(-) NK Cells in Obesity-Associated Cancer
-
E. Mylod; A. M. Melo; N. E. Donlon; M. Davern; A. Bhardwaj; J. V. Reynolds; J. Lysaght; M. J. Conroy
Fractalkine Elicits Chemotactic, Phenotypic, and Functional Effects on CX3CR1(+)CD27(-) NK Cells in Obesity-Associated Cancer J Immunol
The omentum in obesity-associated cancer: A hindrance to effective natural killer cell migration towards tumour which can be overcome by cx3cr1 antagonism
-
E. Mylod; F. O’connell; N. E. Donlon; C. Butler; J. V. Reynolds; J. Lysaght; M. J. Conroy
The omentum in obesity-associated cancer: A hindrance to effective natural killer cell migration towards tumour which can be overcome by cx3cr1 antagonism Cancers
Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses
- E. Molina-Montes; C. Coscia; P. Gómez-Rubio; A. Fernández; R. Boenink; M. Rava; M. Márquez; X. Molero; M. Löhr; L. Sharp; C. W. Michalski; A. Farré; J. Perea; M. O'Rorke; W. Greenhalf; M. Iglesias; A. Tardón; T. M. Gress; V. M. Barberá; T. Crnogorac-Jurce Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses Gut
Leptin and adiponectin receptor expression in oesophageal cancer
-
J. M. Howard; M. C. Cathcart; L. Healy; P. Beddy; C. Muldoon; G. P. Pidgeon; J. V. Reynolds
Leptin and adiponectin receptor expression in oesophageal cancer Br J Surg